O'Dowd, EL;
Lee, RW;
Akram, AR;
Bartlett, EC;
Bradley, SH;
Brain, K;
Callister, MEJ;
... Crosbie, P; + view all
(2023)
Defining the road map to a UK national lung cancer screening programme.
The Lancet Oncology
, 24
(5)
e207-e218.
10.1016/S1470-2045(23)00104-3.
Preview |
Text
Janes_Defining Roadmap UK National Screening Prog v3 clean.pdf - Accepted Version Download (454kB) | Preview |
Abstract
Lung cancer screening with low-dose CT was recommended by the UK National Screening Committee (UKNSC) in September, 2022, on the basis of data from trials showing a reduction in lung cancer mortality. These trials provide sufficient evidence to show clinical efficacy, but further work is needed to prove deliverability in preparation for a national roll-out of the first major targeted screening programme. The UK has been world leading in addressing logistical issues with lung cancer screening through clinical trials, implementation pilots, and the National Health Service (NHS) England Targeted Lung Health Check Programme. In this Policy Review, we describe the consensus reached by a multiprofessional group of experts in lung cancer screening on the key requirements and priorities for effective implementation of a programme. We summarise the output from a round-table meeting of clinicians, behavioural scientists, stakeholder organisations, and representatives from NHS England, the UKNSC, and the four UK nations. This Policy Review will be an important tool in the ongoing expansion and evolution of an already successful programme, and provides a summary of UK expert opinion for consideration by those organising and delivering lung cancer screenings in other countries.
Archive Staff Only
 |
View Item |
